Age modifies both the maximal temperature and inflammatory response in patients with SARS-CoV-2 infection

Clin Med (Lond). 2022 May;22(3):192-196. doi: 10.7861/clinmed.2021-0603.

Abstract

Objective: To determine the maximal response of the temperature and inflammatory response to SARS-CoV-2 infection and how these are modified by age.

Methods: Participants were patients admitted to hospital with SARS-CoV-2 infection. For each participant, the maximal temperature and serum C-reactive protein (CRP) were identified and stratified by age. In a secondary analysis, these were compared in patients treated before and after dexamethasone.

Results: Mean maximal temperature varied by age (p<0.001; ANOVA) with the highest mean maximal temperature of 37.3°C observed in patients aged 30-49 years and decreasing maximal mean temperatures in the older age groups, with the lowest measure of 36.8°C observed in individuals aged 90-99 years. The mean maximal serum CRP also varied across age groups (p<0.001; ANOVA) and increased with age across all age categories from 34.5 mg/dL (95% confidence interval (CI) 22.0-47.0) for individuals aged 20-29 years to 77.6 mg/dL (95% CI 72.0-83.2) in those aged 80-89 years. After dexamethasone became standard treatment for COVID-19 pneumonia, mean maximal CRP decreased by 17 mg/dL (95% CI -22 to -11).

Conclusion: Age modifies both maximal temperature and systemic inflammatory response in patients with SARS-CoV-2 infection.

Keywords: COVID-19; age; infection; inflammation; temperature.

MeSH terms

  • Aged
  • C-Reactive Protein / metabolism
  • COVID-19*
  • Dexamethasone / therapeutic use
  • Hospitalization
  • Humans
  • SARS-CoV-2
  • Temperature

Substances

  • Dexamethasone
  • C-Reactive Protein